- Home
- ONTO vs HALO Comparison
ONTO vs HALO Comparison
Compare ONTO & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ONTO | HALO |
|---|---|---|
| Founded | 1940 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 7.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ONTO | HALO |
|---|---|---|
| Price | $160.77 | $67.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 12 |
| Target Price | ★ $155.00 | $73.33 |
| AVG Volume (30 Days) | 759.0K | ★ 2.2M |
| Earning Date | 02-05-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 56.68 |
| EPS | 3.55 | ★ 4.74 |
| Revenue | $1,002,336,000.00 | ★ $1,242,852,000.00 |
| Revenue This Year | $3.72 | $34.83 |
| Revenue Next Year | $17.29 | $24.84 |
| P/E Ratio | $44.80 | ★ $14.56 |
| Revenue Growth | 6.38 | ★ 31.19 |
| 52 Week Low | $85.88 | $47.50 |
| 52 Week High | $228.42 | $79.50 |
Technical Indicators
Market Signals| Indicator | ONTO | HALO |
|---|---|---|
| Relative Strength Index (RSI) | 59.72 | 51.33 |
| Support Level | $157.19 | $67.95 |
| Resistance Level | $162.58 | $69.48 |
| Average True Range (ATR) | 5.78 | 1.61 |
| MACD | -0.45 | 0.55 |
| Stochastic Oscillator | 57.07 | 72.38 |
Price Performance
Historical ComparisonAbout ONTO Onto Innovation Inc.
Onto Innovation Inc is engaged in the design, development, manufacture, and support of high-performance control metrology, defect inspection, lithography, and data analysis systems used by microelectronics device manufacturers. The Company and its subsidiaries currently operate in a single operating segment. The company mainly operates in the United States, Southeast Asia, China, Japan, and Europe, with Taiwan and South Korea the sources of total revenue.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.